24.93
price up icon1.05%   0.26
after-market After Hours: 24.39 -0.54 -2.17%
loading
Perrigo Company Plc stock is traded at $24.93, with a volume of 687.72K. It is up +1.05% in the last 24 hours and down -1.42% over the past month. Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
See More
Previous Close:
$24.67
Open:
$24.87
24h Volume:
687.72K
Relative Volume:
0.51
Market Cap:
$3.40B
Revenue:
$4.39B
Net Income/Loss:
$-159.70M
P/E Ratio:
-21.31
EPS:
-1.17
Net Cash Flow:
$151.70M
1W Performance:
+0.73%
1M Performance:
-1.42%
6M Performance:
-11.88%
1Y Performance:
-23.88%
1-Day Range:
Value
$24.55
$24.99
1-Week Range:
Value
$24.47
$25.66
52-Week Range:
Value
$23.14
$33.45

Perrigo Company Plc Stock (PRGO) Company Profile

Name
Name
Perrigo Company Plc
Name
Phone
269-673-8451
Name
Address
THE SHARP BUILDING, DUBLIN 2
Name
Employee
9,140
Name
Twitter
@perrigocompany
Name
Next Earnings Date
2024-11-06
Name
Latest SEC Filings
Name
PRGO's Discussions on Twitter

Compare PRGO with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
PRGO
Perrigo Company Plc
24.93 3.40B 4.39B -159.70M 151.70M -1.17
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
172.71 77.92B 9.15B 2.43B 2.31B 5.32
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.70 43.43B 30.27B 1.93B 3.45B 0.6044
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.57 43.27B 14.26B 1.55B 0 0.3383
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
17.84 20.21B 16.77B -959.00M 1.37B -0.85
Drug Manufacturers - Specialty & Generic icon
NBIX
Neurocrine Biosciences Inc
153.29 15.52B 2.24B 385.90M 440.10M 3.73

Perrigo Company Plc Stock (PRGO) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-14-25 Downgrade Argus Buy → Hold
Jan-06-25 Downgrade Piper Sandler Overweight → Neutral
Sep-24-24 Resumed Jefferies Hold
Nov-17-23 Initiated Piper Sandler Overweight
Mar-07-23 Initiated Canaccord Genuity Buy
Sep-14-22 Upgrade Argus Hold → Buy
Sep-06-22 Upgrade Wells Fargo Equal Weight → Overweight
Oct-14-21 Upgrade Raymond James Mkt Perform → Outperform
Sep-30-21 Upgrade Jefferies Hold → Buy
Apr-07-21 Resumed RBC Capital Mkts Sector Perform
Jan-06-21 Downgrade RBC Capital Mkts Outperform → Sector Perform
Apr-17-20 Downgrade Argus Buy → Hold
Mar-24-20 Upgrade JP Morgan Neutral → Overweight
Mar-20-20 Upgrade SVB Leerink Mkt Perform → Outperform
Mar-18-20 Upgrade RBC Capital Mkts Sector Perform → Outperform
Oct-11-19 Upgrade Argus Hold → Buy
Mar-20-19 Initiated SunTrust Hold
Nov-13-18 Downgrade Berenberg Buy → Hold
Aug-10-18 Reiterated Stifel Hold
Jul-30-18 Downgrade Argus Buy → Hold
Jul-12-18 Downgrade Goldman Neutral → Sell
Jan-03-18 Initiated Leerink Partners Mkt Perform
Dec-08-17 Upgrade Argus Hold → Buy
Nov-10-17 Upgrade RBC Capital Mkts Underperform → Sector Perform
Oct-05-17 Reiterated UBS Buy
Sep-07-17 Initiated Oppenheimer Outperform
Aug-11-17 Upgrade Goldman Sell → Neutral
Aug-11-17 Reiterated RBC Capital Mkts Underperform
Jun-16-17 Initiated Cantor Fitzgerald Overweight
Jun-05-17 Downgrade RBC Capital Mkts Sector Perform → Underperform
Mar-03-17 Reiterated B. Riley & Co. Neutral
View All

Perrigo Company Plc Stock (PRGO) Latest News

pulisher
Jan 29, 2025

Toothbrush Market to hit USD 17.19 billion by 2032, says Global Market Insights Inc. - GlobeNewswire Inc.

Jan 29, 2025
pulisher
Jan 28, 2025

Burn pain Market Expected to rise, 2034 | Johnson & Johnson, - openPR

Jan 28, 2025
pulisher
Jan 28, 2025

Strong week for Perrigo (NYSE:PRGO) shareholders doesn't alleviate pain of five-year loss - Yahoo Finance

Jan 28, 2025
pulisher
Jan 28, 2025

Perrigo Paves The Way For Recovery With Margin Focus (NYSE:PRGO) - Seeking Alpha

Jan 28, 2025
pulisher
Jan 27, 2025

Perrigo Co. PLC stock underperforms Monday when compared to competitors despite daily gains - MarketWatch

Jan 27, 2025
pulisher
Jan 24, 2025

Sound Income Strategies LLC Purchases 107,427 Shares of Perrigo Company plc (NYSE:PRGO) - MarketBeat

Jan 24, 2025
pulisher
Jan 24, 2025

Nutraceuticals Market: Trends, Insights, and Growth Forecast 2032 | Glanbia Plc, Perrigo Company Plc - EIN News

Jan 24, 2025
pulisher
Jan 24, 2025

Nisa Investment Advisors LLC Has $7.84 Million Stock Position in Perrigo Company plc (NYSE:PRGO) - MarketBeat

Jan 24, 2025
pulisher
Jan 23, 2025

Objective long/short (PRGO) Report - Stock Traders Daily

Jan 23, 2025
pulisher
Jan 22, 2025

Perrigo Co. PLC stock outperforms competitors despite losses on the day - MarketWatch

Jan 22, 2025
pulisher
Jan 22, 2025

Perrigo Co (MEX:PRGO) Earnings Yield (Joel Greenblatt) % : -0.26% (As of Sep. 2024) - GuruFocus.com

Jan 22, 2025
pulisher
Jan 22, 2025

Clear Harbor Asset Management LLC Sells 20,410 Shares of Perrigo Company plc (NYSE:PRGO) - MarketBeat

Jan 22, 2025
pulisher
Jan 21, 2025

Here’s White Falcon Capital’s Investment Thesis for Perrigo Company plc (PRGO) - MSN

Jan 21, 2025
pulisher
Jan 21, 2025

Perpetual Ltd Reduces Position in Perrigo Company plc (NYSE:PRGO) - MarketBeat

Jan 21, 2025
pulisher
Jan 20, 2025

Perrigo: A Consumer Health Company Close To An Inflection Point - Seeking Alpha

Jan 20, 2025
pulisher
Jan 20, 2025

White Falcon Capital Q4 2024 Partner's Letter - Seeking Alpha

Jan 20, 2025
pulisher
Jan 19, 2025

Perrigo Co (BSP:P1RG34) Altman Z-Score : 0.67 (As of Jan. 19, 2025) - GuruFocus.com

Jan 19, 2025
pulisher
Jan 19, 2025

Perrigo Co (BSP:P1RG34) 3-Year Revenue Growth Rate : 4.90% (As of Sep. 2024) - GuruFocus.com

Jan 19, 2025
pulisher
Jan 19, 2025

O Keefe Stevens Advisory Inc. Has $5.09 Million Stock Position in Perrigo Company plc (NYSE:PRGO) - MarketBeat

Jan 19, 2025
pulisher
Jan 19, 2025

PRGO (Perrigo Co) Growth Rank : 1 (As of Jan. 19, 2025) - GuruFocus.com

Jan 19, 2025
pulisher
Jan 18, 2025

PRGO (Perrigo Co) Median PS Value : $54.95 (As of Jan. 18, 2025) - GuruFocus.com

Jan 18, 2025
pulisher
Jan 16, 2025

Perrigo Company plc Appoints Jonas Samuelson to as A Member of Board of Directors and Audit Committee and the Nominating and Governance Committee - Marketscreener.com

Jan 16, 2025
pulisher
Jan 16, 2025

Perrigo Co. PLC stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch

Jan 16, 2025
pulisher
Jan 14, 2025

Perrigo cut to Hold at Argus on topline risks - MSN

Jan 14, 2025
pulisher
Jan 14, 2025

Perrigo Sees Unusually Large Options Volume (NYSE:PRGO) - MarketBeat

Jan 14, 2025
pulisher
Jan 14, 2025

Perrigo (NYSE:PRGO) Hits New 12-Month LowHere's What Happened - MarketBeat

Jan 14, 2025
pulisher
Jan 14, 2025

Perrigo Company plc (NYSE:PRGO) Receives Average Rating of "Hold" from Analysts - MarketBeat

Jan 14, 2025
pulisher
Jan 14, 2025

Perrigo stock cut to hold at Argus on topline risk (PRGO:NYSE) - Seeking Alpha

Jan 14, 2025
pulisher
Jan 14, 2025

Perrigo stock hits 52-week low at $23.86 amid market challenges - Investing.com India

Jan 14, 2025
pulisher
Jan 14, 2025

Perrigo (NYSE:PRGO) Stock Rating Lowered by Argus - MarketBeat

Jan 14, 2025
pulisher
Jan 12, 2025

(PRGO) Investment Report - Stock Traders Daily

Jan 12, 2025
pulisher
Jan 12, 2025

JPMorgan Chase & Co. Purchases 213,221 Shares of Perrigo Company plc (NYSE:PRGO) - MarketBeat

Jan 12, 2025
pulisher
Jan 11, 2025

Perrigo (NYSE:PRGO) Lowered to "Hold" Rating by StockNews.com - MarketBeat

Jan 11, 2025
pulisher
Jan 10, 2025

Perrigo Co. PLC stock underperforms Friday when compared to competitors - MarketWatch

Jan 10, 2025
pulisher
Jan 09, 2025

US Consumer Health People Moves: Perrigo Science And Haleon US Customer Chiefs, More - News & Insights

Jan 09, 2025
pulisher
Jan 08, 2025

Perrigo Co. PLC stock outperforms competitors on strong trading day - MarketWatch

Jan 08, 2025
pulisher
Jan 08, 2025

The past five years for Perrigo (NYSE:PRGO) investors has not been profitable - Simply Wall St

Jan 08, 2025
pulisher
Jan 07, 2025

Perrigo Co. PLC stock underperforms Tuesday when compared to competitors - MarketWatch

Jan 07, 2025
pulisher
Jan 07, 2025

Perrigo appoints Abbie Lennox as new Chief Scientific Officer By Investing.com - Investing.com Australia

Jan 07, 2025
pulisher
Jan 07, 2025

Piper Sandler Downgrades Perrigo (PRGO) - MSN

Jan 07, 2025
pulisher
Jan 06, 2025

Perrigo Expands its Scientific Office; Appoints Abbie Lennox as - GuruFocus.com

Jan 06, 2025
pulisher
Jan 06, 2025

Perrigo (NYSE:PRGO) Downgraded to "Neutral" Rating by Piper Sandler - MarketBeat

Jan 06, 2025
pulisher
Jan 06, 2025

Perrigo downgraded by Piper Sandler with a new price target - Quantisnow

Jan 06, 2025
pulisher
Jan 06, 2025

Perrigo appoints Abbie Lennox as new Chief Scientific Officer - Investing.com

Jan 06, 2025
pulisher
Jan 06, 2025

Perrigo Expands its Scientific Office; Appoints Abbie Lennox as Executive Vice President and Chief Scientific Officer - Marketscreener.com

Jan 06, 2025
pulisher
Jan 05, 2025

Perrigo to Release Second Quarter 2023 Financial Results and Pre - GuruFocus.com

Jan 05, 2025
pulisher
Jan 03, 2025

Perrigo (NYSE:PRGO) Stock Rating Lowered by StockNews.com - MarketBeat

Jan 03, 2025
pulisher
Jan 01, 2025

Principal Financial Group Inc. Has $8.29 Million Position in Perrigo Company plc (NYSE:PRGO) - MarketBeat

Jan 01, 2025
pulisher
Dec 25, 2024

153,711 Shares in Perrigo Company plc (NYSE:PRGO) Bought by Franklin Resources Inc. - MarketBeat

Dec 25, 2024
pulisher
Dec 24, 2024

Perrigo Company plc (NYSE:PRGO) Stake Raised by Barclays PLC - MarketBeat

Dec 24, 2024
pulisher
Dec 23, 2024

Infant Formula Market is Going to Booming Growth 2024-2031 | Perrigo Company plc, Bellamy's Organic. , Glanbia plc - openPR

Dec 23, 2024

Perrigo Company Plc Stock (PRGO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$31.91
price up icon 1.11%
$12.47
price up icon 1.46%
$92.79
price up icon 0.28%
$127.00
price down icon 0.02%
$11.42
price up icon 0.79%
$153.29
price up icon 1.73%
Cap:     |  Volume (24h):